Sus Clinicals develops the Oncopig Cancer Model, a proprietary platform utilizing genetically-engineered pigs for preclinical testing of cancer therapeutics. This approach provides a more predictive model for identifying effective drugs and diagnostics, thereby enhancing the success rate of human clinical trials.
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Preclinical testing of cancer therapeutics often relies on mouse models, which may not accurately predict drug efficacy and safety in humans due to significant physiological differences. Traditional large animal models are costly, time-consuming, and may not develop tumors and comorbidities relevant to human disease on demand.
Solution
Sus Clinicals offers the Oncopig Cancer Model, a genetically engineered pig platform designed to bridge the gap between mouse models and human clinical trials. The Oncopig platform enables researchers to induce relevant tumors and comorbidities on demand, allowing for more predictive testing of medical devices, diagnostics, and drug candidates. This porcine model closely mimics human physiology, providing a more accurate and efficient way to assess the efficacy and safety of cancer therapeutics before human trials. Sus Clinicals collaborates with research institutions that have large animal testing capabilities to accelerate the qualification of potentially life-saving cancer treatments.
Target Audience
Sus Clinicals serves pharmaceutical companies, medical device developers, contract research organizations (CROs), and research institutions involved in preclinical cancer research and drug development.
Features
- Genetically-engineered pigs that develop tumors and comorbidities relevant to human cancers
- FDA-cleared large animal genome editing research platform
- Clinically relevant imaging modalities for tracking tumor formation
- Capability to induce tumors on demand
- Fresh and frozen tissues/liquids available
- Cell lines and genetically defined cell lines available
- Histology services